Thomas Appio

Thomas Appio discloses dealings in Valeant Pharmaceuticals International, Inc. to SEDI. Over a trading history stretching from 10 May 2017 to 8 January 2018, the count stands at 6 filings.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

Most recently, on 10 January 2018, the filings show a transaction worth €25k in Valeant Pharmaceuticals International, Inc. The median gap between a trade and its publication by SEDI is 5 days. That lag is the time during which only the insider knows about the trade. This summary is built from SEDI disclosures alone and does not predict where the share price will go.